These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33007738)

  • 1. Phenotyping of hypertensive heart disease and hypertrophic cardiomyopathy using personalized 3D modelling and cardiac cine MRI.
    Chuah SH; Md Sari NA; Chew BT; Tan LK; Chiam YK; Chan BT; Lim E; Abdul Aziz YF; Liew YM
    Phys Med; 2020 Oct; 78():137-149. PubMed ID: 33007738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertensive heart disease versus hypertrophic cardiomyopathy: multi-parametric cardiovascular magnetic resonance discriminators when end-diastolic wall thickness ≥ 15 mm.
    Rodrigues JC; Rohan S; Ghosh Dastidar A; Harries I; Lawton CB; Ratcliffe LE; Burchell AE; Hart EC; Hamilton MC; Paton JF; Nightingale AK; Manghat NE
    Eur Radiol; 2017 Mar; 27(3):1125-1135. PubMed ID: 27368925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular magnetic resonance feature tracking strain analysis for discrimination between hypertensive heart disease and hypertrophic cardiomyopathy.
    Neisius U; Myerson L; Fahmy AS; Nakamori S; El-Rewaidy H; Joshi G; Duan C; Manning WJ; Nezafat R
    PLoS One; 2019; 14(8):e0221061. PubMed ID: 31433823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Integrated Algorithm for Differentiating Hypertrophic Cardiomyopathy From Hypertensive Heart Disease.
    Kong LC; Wu LM; Wang Z; Liu C; He B
    J Magn Reson Imaging; 2023 Oct; 58(4):1084-1097. PubMed ID: 36688928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and predictors of asymmetric hypertensive heart disease: insights from cardiac and aortic function with cardiovascular magnetic resonance.
    Rodrigues JC; Amadu AM; Dastidar AG; Hassan N; Lyen SM; Lawton CB; Ratcliffe LE; Burchell AE; Hart EC; Hamilton MC; Paton JF; Nightingale AK; Manghat NE
    Eur Heart J Cardiovasc Imaging; 2016 Dec; 17(12):1405-1413. PubMed ID: 26705488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Texture analysis applied in T1 maps and extracellular volume obtained using cardiac MRI in the diagnosis of hypertrophic cardiomyopathy and hypertensive heart disease compared with normal controls.
    Shi RY; Wu R; An DL; Chen BH; Wu CW; Du L; Jiang M; Xu JR; Wu LM
    Clin Radiol; 2021 Mar; 76(3):236.e9-236.e19. PubMed ID: 33272531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular structure and diastolic function by cardiac magnetic resonance imaging in hypertrophic cardiomyopathy.
    Chacko BR; Karur GR; Connelly KA; Yan RT; Kirpalani A; Wald R; Jimenez-Juan L; Jacob JR; Deva DP; Yan AT
    Indian Heart J; 2018; 70(1):75-81. PubMed ID: 29455792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypertrophic cardiomyopathy with dilatation of the left ventricle and congestive heart failure: comparison with postmyocarditis cardiomegaly and hypertensive heart failure].
    Kawanishi H; Yokota Y; Hayakawa M; Kaku K; Kumaki T; Matsumoto K; Fujitani K; Ito Y; Inoh T; Fukuzaki H
    J Cardiogr; 1983 Sep; 13(3):537-50. PubMed ID: 6235295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI differentiation of cardiomyopathy showing left ventricular hypertrophy and heart failure: differentiation between cardiac amyloidosis, hypertrophic cardiomyopathy, and hypertensive heart disease.
    Takeda M; Amano Y; Tachi M; Tani H; Mizuno K; Kumita S
    Jpn J Radiol; 2013 Oct; 31(10):693-700. PubMed ID: 23996116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrimination models with radiomics features derived from cardiovascular magnetic resonance images for distinguishing hypertensive heart disease from hypertrophic cardiomyopathy.
    Zhang H; Tian J; Zhang C; Wang H; Hui K; Wang T; Chai S; Schoenhagen P; Zhao L; Ma X
    Cardiovasc Diagn Ther; 2024 Feb; 14(1):129-142. PubMed ID: 38434569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
    Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
    Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.
    Hinojar R; Varma N; Child N; Goodman B; Jabbour A; Yu CY; Gebker R; Doltra A; Kelle S; Khan S; Rogers T; Arroyo Ucar E; Cummins C; Carr-White G; Nagel E; Puntmann VO
    Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26659373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiomic Analysis of Myocardial Native T
    Neisius U; El-Rewaidy H; Nakamori S; Rodriguez J; Manning WJ; Nezafat R
    JACC Cardiovasc Imaging; 2019 Oct; 12(10):1946-1954. PubMed ID: 30660549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Cardiac Magnetic Resonance Feature Tracking (CMR-FT) Analysis for Detection of Myocardial Fibrosis in Pediatric Hypertrophic Cardiomyopathy.
    Bogarapu S; Puchalski MD; Everitt MD; Williams RV; Weng HY; Menon SC
    Pediatr Cardiol; 2016 Apr; 37(4):663-73. PubMed ID: 26833321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tricuspid annular motion velocity as a differentiation index of hypertrophic cardiomyopathy from hypertensive heart disease.
    Hayashi S; Yamada H; Nishio S; Hotchi J; Bando M; Takagawa Y; Saijo Y; Hirata Y; Sata M
    J Cardiol; 2015 Jun; 65(6):519-25. PubMed ID: 25199979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T1 Mapping and Extracellular Volume in Cardiomyopathy Showing Left Ventricular Hypertrophy: Differentiation Between Hypertrophic Cardiomyopathy and Hypertensive Heart Disease.
    Liang L; Wang X; Yu Y; Zhang Y; Liu J; Chen M; Zhang L; Jiang T
    Int J Gen Med; 2022; 15():4163-4173. PubMed ID: 35465304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep Learning for Discrimination of Hypertrophic Cardiomyopathy and Hypertensive Heart Disease on MRI Native T1 Maps.
    Wang ZC; Fan ZZ; Liu XY; Zhu MJ; Jiang SS; Tian S; Chen BH; Wu LM
    J Magn Reson Imaging; 2024 Mar; 59(3):837-848. PubMed ID: 37431848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of athlete's heart from pathological forms of cardiac hypertrophy by means of geometric indices derived from cardiovascular magnetic resonance.
    Petersen SE; Selvanayagam JB; Francis JM; Myerson SG; Wiesmann F; Robson MD; Ostman-Smith I; Casadei B; Watkins H; Neubauer S
    J Cardiovasc Magn Reson; 2005; 7(3):551-8. PubMed ID: 15959967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy.
    Rickers C; Wilke NM; Jerosch-Herold M; Casey SA; Panse P; Panse N; Weil J; Zenovich AG; Maron BJ
    Circulation; 2005 Aug; 112(6):855-61. PubMed ID: 16087809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance.
    Maron MS; Maron BJ; Harrigan C; Buros J; Gibson CM; Olivotto I; Biller L; Lesser JR; Udelson JE; Manning WJ; Appelbaum E
    J Am Coll Cardiol; 2009 Jul; 54(3):220-8. PubMed ID: 19589434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.